Benzinga | May 4, 2021 04:14PM EDT

Aptose Biosciences Q1 EPS $(0.18) Misses $(0.14) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same period last year.